This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Innovations of Nguyen Thanh in Pharmaceutical Chemistry
Introduction
Nguyen Thanh is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective treatments for various infections.
Latest Patents
Nguyen Thanh holds a patent for "Fused heterocycles as inhibitors of glutamate racemase (MURI)." This invention relates to novel compounds having specific formulas and their pharmaceutical compositions. The compounds developed by Nguyen Thanh provide a treatment or prophylaxis for infections, showcasing his innovative approach to addressing medical challenges.
Career Highlights
Nguyen Thanh is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Nguyen Thanh collaborates with esteemed colleagues, including Marshall Morningstar and Gregory Steven Basarab. These partnerships enhance the research efforts and contribute to the advancement of pharmaceutical innovations.
Conclusion
Nguyen Thanh's contributions to pharmaceutical chemistry through his patent and work at AstraZeneca highlight his commitment to innovation in the medical field. His research continues to pave the way for new treatments that can significantly impact public health.